+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Agenus Inc - logo

Agenus is an immuno-oncology company that focuses on the discovery and development of treatments that engage the body's immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates. It is also developing Prophage, a heat shock protein-based autologous vaccine. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

From
Vaccine Adjuvants - Global Strategic Business Report - Product Thumbnail Image

Vaccine Adjuvants - Global Strategic Business Report

  • Report
  • May 2025
  • 193 Pages
  • Global
From
Therapeutic Vaccines - Global Strategic Business Report - Product Thumbnail Image

Therapeutic Vaccines - Global Strategic Business Report

  • Report
  • May 2025
  • 182 Pages
  • Global
From
Immunology Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Immunology Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 450 Pages
  • Global
From
From
From
From
Vaccine Adjuvants Market Report 2025 - Product Thumbnail Image

Vaccine Adjuvants Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Plant-Based Vaccines Market Report 2025 - Product Thumbnail Image

Plant-Based Vaccines Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
CTLA4 Inhibitors Market 2025-2029 - Product Thumbnail Image

CTLA4 Inhibitors Market 2025-2029

  • Report
  • February 2025
  • 204 Pages
  • Global
From
From
Loading Indicator